Survey Finds Growing Interest In Continuous Manufacturing Of New Drugs

22 Apr 2019
News

Joanne S. Eglovitch joanne.eglovitch@informa.com

Executive Summary

A recent survey shows that pharmaceutical manufacturers are increasingly interested in adopting continuous manufacturing. Most respondents say they plan to use this mode of manufacturing for their new drugs.

Already Registered? Sign in to continue reading.

New to Pink Sheet? Start a free trial today!

Table
View full table

Topics

Subjects
Manufacturing
Quality
Industries
BioPharmaceutical

ASK THE ANALYST
Email

Print
Bookmark
Share

Tags:

Manufacturing Quality BioPharmaceutical

You must sign in to use this functionality

Authentication.SignIn.HeadSignInHeader

PS125143

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

PS125143

All set! This article has been sent to my@email.address.

All fields are required. For multiple recipients, separate email addresses with a semicolon.

Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.

Survey Finds Growing Interest In Continuous Manufacturing Of New Drugs

News

Executive Summary

Related Content

FDA Drafts Guidance To Spur Uptake In Continuous Manufacturing

Pharma Industry Still Not At 'Tipping Point' In Adopting Continuous Manufacturing

Topics

You must sign in to use this functionality

Authentication.SignIn.HeadSignInHeader

Register

Ask The Analyst

Email Article

Sign In To Set a Search Alert